Solubility-Modulated Asymmetric Membrane Tablets of Triprolidine Hydrochloride: Statistical Optimization and Evaluation
- 394 Downloads
The aim of the present study was to develop asymmetric membrane (AM) tablets for controlled delivery of highly water-soluble antihistaminic drug triprolidine hydrochloride. The solubility of triprolidine hydrochloride was modulated through the incorporation of coated sodium chloride crystals encapsulated with asymmetric membrane coating polymer, cellulose acetate butyrate. Formulation of AM tablets was based on a 23 factorial design to study the effect of formulation variables, namely, polymer concentration, level of pore former, and amount of osmogen on the in vitro release. Core tablets prepared by wet granulation and coated with asymmetric membrane by a dip coating method were evaluated. Statistical analysis was done with the Design Expert Software 8.0.2 (USA), and the polynomial equation generated by Pareto charts was used for validation of the experimental design. The interaction chart and response surface plots deduced the simultaneous effect of independent variables on in vitro drug release. The in vitro drug release was inversely proportional and directly related to the level(s) of polymer and pore former in the membrane, respectively. The level of osmogen not only increased the osmotic pressure but also controlled the drug release due to a common ion effect. The drug release of the optimized formulation (F6) followed zero-order kinetics, which would be capable of reducing the administration, and was stable over 3 months. SEM photographs revealed asymmetry in membrane structure.
KEY WORDSasymmetric membrane coated sodium chloride cellulose acetate butyrate solubility modulation 23 factorial design
The authors are greatly thankful to the Indian Institute of Technology, New Delhi, India, for extending facilities for SEM for the characterization of asymmetric membrane and AICTE, India, for providing financial assistance to Mr. Rahul Dev.
- 10.Singh H, Philip AK, Pathak K. Multiple unit asymmetric membrane capsule: a means for delivery of highly water soluble drug. Int J Drug Del Tech. 2009;1(1):9–16.Google Scholar
- 11.Banker GS, Anderson NR. Tablets: the theory and practice of industrial pharmacy, 3rd ed. Lechman L, Lieberman AH, Kaning LJ, editors. Bombay: Varghese Publishing House; 2003. p 294.Google Scholar
- 12.Florey K. Analytical profiles of drug substances, vol. 19. London: Academic; 2005. p. 161–78.Google Scholar
- 13.Tripathi KD. Essentials of medical pharmacology, 5th ed. 2003; New Delhi. India. p 698.Google Scholar
- 16.Government of India, Ministry of Health and Family Welfare, Indian Pharmacopoeia. The Indian Pharmacopoeia Commission, Ghaziabad; 2007; p. 1835.Google Scholar
- 17.Maffat CA, Osetton DM, Brian W. Clarke’s analysis of drugs and poisons. 3rd ed. London: Pharmaceutical Press; 2004. p. 1683.Google Scholar
- 21.Higuchi T. Mechanism of sustained action medication, theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963; 52: 1145Y1149.Google Scholar
- 22.Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation: I—Theoretical consideration. Ind Eng Chem. 1931; 23:923Y931.Google Scholar
- 23.Bolton S. Pharmaceutical statistics: practical and clinical applications. 2nd ed. New York: Marcel Dekker; 1990. p. 444–6.Google Scholar
- 25.Larsen C, Schulz B, Poulsen SV, Ostergaard J, Larsen SW. Diffusional salts of bupivacaine, lidocaine and morphine use of common ion effect for prolonging the release of bupivacaine from mixed salt suspensions in an in vitro dialysis model. Eur J Pharm Biopharm. 2007;31:172–9.Google Scholar
- 26.Philip AK, Pathak K. Insitu formed asymmetric membrane capsule for delivery of poorly water soluble drugs. PDA J Pharm Sci Tech. 2007;61(1):24–36.Google Scholar